Innovative immunotherapy shows promise against aggressive T cell cancers (IMAGE)

WashU Medicine

Innovative immunotherapy shows promise against aggressive T cell cancers

Caption

An international clinical trial led by WashU Medicine researchers shows an innovative CAR-T cell immunotherapy is promising against aggressive T cell cancers and has manageable side effects. Armin Ghobadi, MD, prepares the new “universal” CAR-T cell product for a patient’s infusion as part of a clinical trial at Siteman Cancer Center, based at Barnes-Jewish Hospital and WashU Medicine.

Credit

Matt Miller/WashU Medicine

Usage Restrictions

Please credit Matt Miller/WashU Medicine

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.